GLAXO

GlaxoSmithKline Pharmaceuticals Pivot Points

₹2,645.80-3.96%
Market cap
₹44,821 crore
P/E
42.0
P/B
19.77
ROE
49.1%
Dividend yield
1.20%

Based on the 7 October 2026 session (high ₹2,685.49, low ₹2,606.11, close ₹2,645.80), the classic daily pivot for GlaxoSmithKline Pharmaceuticals is ₹2,645.80, with first resistance at ₹2,685.49 and first support at ₹2,606.11. The central pivot range runs from ₹2,645.80 to ₹2,645.80, 0.00% wide.

Period used for each timeframe

High, low and close used to calculate GlaxoSmithKline Pharmaceuticals pivot levels (₹)
TimeframePeriodHighLowClose
Daily7 Oct 20262,685.492,606.112,645.80
Weekly7 Oct 2026 – 7 Oct 20262,738.402,553.202,645.80
Monthly7 Oct 2026 – 7 Oct 20262,844.242,447.372,645.80

Classic pivot points

GlaxoSmithKline Pharmaceuticals classic pivot levels (₹)
LevelDailyWeeklyMonthly
R32,764.872,923.603,241.11
R22,725.182,831.003,042.67
R12,685.492,738.402,844.24
Pivot2,645.802,645.802,645.80
S12,606.112,553.202,447.37
S22,566.422,460.602,248.93
S32,526.732,368.002,050.50

Fibonacci pivot points

GlaxoSmithKline Pharmaceuticals fibonacci pivot levels (₹)
LevelDailyWeeklyMonthly
R32,725.182,831.003,042.67
R22,694.862,760.252,891.07
R12,676.122,716.552,797.41
Pivot2,645.802,645.802,645.80
S12,615.482,575.052,494.20
S22,596.742,531.352,400.54
S32,566.422,460.602,248.93

Camarilla pivot points

GlaxoSmithKline Pharmaceuticals camarilla pivot levels (₹)
LevelDailyWeeklyMonthly
R42,689.462,747.662,864.08
R32,667.632,696.732,754.94
R22,660.352,679.752,718.56
R12,653.082,662.782,682.18
Pivot2,645.802,645.802,645.80
S12,638.522,628.822,609.42
S22,631.252,611.852,573.04
S32,623.972,594.872,536.66
S42,602.142,543.942,427.52

Woodie pivot points

GlaxoSmithKline Pharmaceuticals woodie pivot levels (₹)
LevelDailyWeeklyMonthly
R32,764.872,923.603,241.10
R22,725.182,831.003,042.67
R12,685.492,738.402,844.23
Pivot2,645.802,645.802,645.80
S12,606.112,553.202,447.36
S22,566.422,460.602,248.93
S32,526.732,368.002,050.49

Central pivot range (CPR)

GlaxoSmithKline Pharmaceuticals central pivot range by timeframe (₹)
TimeframeTop (TC)PivotBottom (BC)Width
Daily2,645.802,645.802,645.800.00%
Weekly2,645.802,645.802,645.800.00%
Monthly2,645.802,645.802,645.800.00%

Source: Calculated by ATS from NSE end-of-day high, low and close prices. Data as of 7 October 2026. How this data is compiled.

GlaxoSmithKline Pharmaceuticals pivot points — frequently asked questions

What is the GlaxoSmithKline Pharmaceuticals pivot point today?

The classic daily pivot point for GlaxoSmithKline Pharmaceuticals (GLAXO) is ₹2,645.80, calculated from the 7 October 2026 session's high, low and close. It applies to the next trading session.

What are the support and resistance levels for GlaxoSmithKline Pharmaceuticals?

Classic daily levels: resistance at ₹2,685.49 (R1), ₹2,725.18 (R2) and ₹2,764.87 (R3); support at ₹2,606.11 (S1), ₹2,566.42 (S2) and ₹2,526.73 (S3). Fibonacci, Camarilla and Woodie levels are in the tables above.

What is the GlaxoSmithKline Pharmaceuticals weekly pivot?

The classic weekly pivot is ₹2,645.80, from the week of 7 Oct 2026 to 7 Oct 2026, with weekly resistance at ₹2,738.40 and support at ₹2,553.20.

How are pivot points calculated?

The classic pivot is the average of the previous period's high, low and close: PP = (H + L + C) / 3. Resistance R1 = 2 × PP − L and support S1 = 2 × PP − H; R2 and S2 add or subtract the high-low range. Fibonacci levels apply 38.2%, 61.8% and 100% of the range to the pivot, Camarilla levels are built around the close, and Woodie weights the close twice.

Same Data For Peers

💡 LearnHow pivot points and support levels work →

Trade GlaxoSmithKline Pharmaceuticals With ATS

Track GLAXO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

GlaxoSmithKline Pharmaceuticals share priceOpen a demat account →Brokerage calculator

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.